Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Ocean Biomedical, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 3.58M | 3.68M | +96.6K (+2.7%) |
| Value | $3.46M | $2.01M | −$1.46M (−42.1%) |
New holders (4)
Institutions that held Ocean Biomedical, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 20,450 | $11.3K | 0.00% |
| BNP Paribas Arbitrage, SA | 143 | $79 | 0.00% |
| SBI Securities Co., Ltd. | 17 | $9 | 0.00% |
| Simplex Trading, LLC | 1,555 | $0 | 0.00% |
Sold out (3)
Institutions that held Ocean Biomedical, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| XTX Topco Ltd | 18,562 | $18.2K |
| Nordwand Advisors, LLC | 2,000 | $1.96K |
| Morgan Stanley | 399 | $391 |